Åshild Lunde
University of Bergen
4 Papers
Åshild Lunde is an academic researcher from University of Bergen. The author has contributed to research in topics: Reflexivity & Research ethics. The author has an hindex of 2, co-authored 3 publications.
Chat about Author
Papers
The Global State of the Genetic Counseling Profession.
Mary Ann R. Abacan,Lamia Alsubaie,Kristine Barlow-Stewart,Beppy Caanen,Christophe Cordier,Eliza Courtney,Emeline Davoine,Janice G. Edwards,Niby J. Elackatt,Kate Gardiner,Yue Guan,Lian-Hua Huang,Lian-Hua Huang,Charlotta Ingvoldstad Malmgren,Sahil Kejriwal,Hyon J. Kim,Deborah M. Lambert,Paulina Araceli Lantigua-Cruz,Juliana M. H. Lee,Marianne Lodahl,Åshild Lunde,Shelley Macaulay,Ivan Macciocca,Sonia Margarit,Anna Middleton,Ramona Moldovan,Joanne Ngeow,Alexandra J Obregón-Tito,Kelly E. Ormond,Milena Paneque,Karen P. Powell,Kunal Sanghavi,Diana Scotcher,Jenna Scott,Clara Serra Juhé,Shiri Shkedi-Rafid,Tina-Marié Wessels,Sook-Yee Yoon,Sook-Yee Yoon,Catherine Wicklund +39 more
TL;DR: The global state of genetic counseling as a profession is described as fully as possible, estimating that in 2018 there are nearly 7000 genetic counselors with the profession established or developing in no less than 28 countries.
314
Researcher-researched relationship in qualitative research: Shifts in positions and researcher vulnerability
Målfrid Råheim,Liv Heide Magnussen,Ragnhild Johanne Tveit Sekse,Åshild Lunde,Torild Jacobsen,Astrid Blystad +5 more
TL;DR: A group of health science researchers anchored in various qualitative research traditions gathered in reflective group discussions over a period of two years and indicated a number of similar experiences which can shed light on the researcher-researched relationship.
283
Comparing prenatal screening experiences of Icelandic women who received false‐positive and true‐negative first‐trimester combined screening results in Iceland in 2012–2016
Eirny Thorolfsdottir,Åshild Lunde,Vigdis Stefansdottir,Hulda Hjartardottir,Kristin Rut Haraldsdottir +4 more
TL;DR: NIPT is worth considering as Iceland's standard first-tier screening method for trisomy 13, 18, and 21, and the findings of this study are beneficial not only for Iceland but also for other countries where FTS is the first- tier prenatal screening method or the only offered test.
Evaluating the Rosa chatbot: A qualitative study of how receiving genetic information via a chatbot is perceived by patients at risk of hereditary breast and ovarian cancer. (Preprint)
Elen Siglen,Hildegunn Hoøberg Vetti,Mirjam Tonheim Augestad,Vidar M. Steen,Åshild Lunde,Cathrine Bjorvatn +5 more
TL;DR: The results indicate that a genetic information chatbot has the potential to contribute to easy access to uniform information for patients at risk of hereditary breast and ovarian cancer, regardless of geographical location.